Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2563360 | 0.86 | TSHR (0.33) | LMNAHSD17B10 | |
| SCHEMBL3173392 | 0.81 | TSHR (0.38) | LMNA | |
| SCHEMBL11494581 | 0.79 | TSHR (0.37) | — | |
| SCHEMBL27732056 | 0.77 | GGPS1 (0.31) | — | |
| SCHEMBL9720003 | 0.77 | GGPS1 (0.33) | LMNA | |
| SCHEMBL28243052 | 0.77 | GGPS1 (0.33) | LMNA | |
| SCHEMBL11646996 | 0.76 | TSHR (0.39) | LMNA | |
| SCHEMBL16287051 | 0.75 | TSHR (0.38) | LMNAHSD17B10 | |
| SCHEMBL598335 | 0.75 | TSHR (0.38) | LMNA | |
| SCHEMBL17420817 | 0.75 | TSHR (0.38) | LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112041364-B | Two-component adhesive composition based on phosphate-modified isocyanates and method for the production thereof | 陶氏环球技术有限责任公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-112041364-A | Two-component adhesive composition based on phosphate-modified isocyanates and method for the production thereof | 陶氏环球技术有限责任公司 | 2020-12-04 | — | — | CN | disclosed |
| EP-2847246-B1 | PREPARATION OF POLYISOCYANATES HAVING ISOCYANURATE GROUPS AND THEIR USE | BASF SE (DE) | 2016-04-20 | — | — | EP | disclosed |
| US-8742166-B2 | Preparation of polyisocyanates having isocyanurate groups and their use | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-20130303758-A1 | PREPARATION OF POLYISOCYANATES HAVING ISOCYANURATE GROUPS AND THEIR USE | BASF SE (DE) | 2013-11-14 | — | — | US | disclosed |
| US-8119799-B2 | Method for the production of polyisocyanates comprising isocyanurate groups and use therof | BASF AKTIENGESELLSCHAFT (DE) | 2012-02-21 | — | — | US | disclosed |
| US-20070197759-A1 | Method for the production of polyisocyanates comprising isocyanurate groups and use therof | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303758-A1 | PREPARATION OF POLYISOCYANATES HAVING ISOCYANURATE GROUPS AND THEIR USE | UROD, ACMSD, DDC | LMNA 3527/4885HSD17B10 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.